Door Pharmaceuticals
Bloomington, IN Doing business as Door Pharmaceuticals
- UEI
- QG12JNBD6KZ3
- CAGE
- 80QJ4
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 615 S Clifton Ave, Bloomington, IN 47401, USA
- Website
- doorpharma.com
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Advancing HBV antivirals that suppress viral replication and hbsag production - summary chronic hepatitis b virus… | National Institute of Allergy and Infectious Diseases | $314,363 | |
| A new class of antiviral directed at HBV capsid protein - abstract chronic hepatitis b virus (HBV) affects 240-300… | National Institute of Allergy and Infectious Diseases | $613,000 |
Quick answers
What is Door Pharmaceuticals's UEI?
Door Pharmaceuticals's Unique Entity ID (UEI) in SAM.gov is QG12JNBD6KZ3.
What is Door Pharmaceuticals's CAGE code?
Door Pharmaceuticals's CAGE code is 80QJ4.
Where is Door Pharmaceuticals located?
Door Pharmaceuticals's physical address in SAM.gov is 615 S Clifton Ave, Bloomington, IN 47401, USA.
Is Door Pharmaceuticals registered in SAM.gov?
Yes. Door Pharmaceuticals's SAM.gov registration is active through March 13, 2027.
What is Door Pharmaceuticals's most recent federal award?
Door Pharmaceuticals's most recent federal grant award is Advancing HBV antivirals that suppress viral replication and hbsag production - summary chronic hepatitis b virus… (R43AI195101), from National Institute of Allergy and Infectious Diseases, on July 8, 2026.
On GovTribe
See Door Pharmaceuticals's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors